baber/WOPTO huggingface dataset:
Patent WO-2020082101-A1 (WO)
Inventor: AHAMMER CHRISTIAN
IPC: B65G1/137
Filed: 2019-10-23
Abstract: Die Erfindung betrifft ein Verfahren zum Kommissionieren von Waren (WQ1', WQ2, WQ2', WZ1, WZ1', WZ2) von Quell-Ladehilfsmitteln (Q1, Q1', Q2, Q2') in oder auf Ziel- Ladehilfsmittel (Z1, Ζ1', Z2, Z3) in einem Lager- und Kommissioniersystem (1). Die Waren (WQ1', WQ2, WQ2', WZ1, WZ1', WZ2) gehören dabei einer ersten Warentypengruppe (WTG1) an, deren Warentypen (WT1..WT3) automatisch handhabbar sind, oder einer zweiten Warentypengruppe (WTG2), deren Warentypen (WT1..WT3) manuell handhabbar sind. Ein erster Auftragsteil (AT1) mit Waren (WQ1', WZ1, WZ1') der ersten Warentypengruppe (WTG1) wird zu einer ersten automatischen Kommissionierstation (KA1, ΚΑ1') transportiert und dort kommissioniert, und ein zweiter Auftrag steil (AT2) mit Waren (WQ2, WQ2', WZ2) der zweiten Warentypengruppe (WTG2) ) wird zu einer ersten manuellen Kommissionierstation (KM1, ΚΜ1') transportiert und dort kommissioniert. Weiterhin betrifft die Erfindung ein Lager- und Kommissioniersystem (1) zur Durchführung des genannten Verfahrens.
Patent WO-2020107043-A1 (WO)
Inventor: WALDSCHÜTZ GERHARD
IPC: H01M50/51
Filed: 2019-10-29
Abstract: Es wird eine Vorrichtung zum unabhängigen Kontaktieren zweier Batteriezellen, mit einem eine Durchtrittsöffnung (6) aufweisenden Grundkörper beschrieben. Um nicht nur einen einfacheren, modulareren Assemblierungsvorgang, sondern auch einen schnellen Austausch einzelner Batteriezellen zu ermöglichen, wird vorgeschlagen, dass der Grundkörper (1) zwei bezüglich der Durchtrittsöffnung (6) gegenüberliegende Aufnahmekörper (2,3) zum umfangsseitigen Umgreifen jeweils eines Endabschnittes der in einer Fügerichtung in die Aufnahmekörper (2,3) eingesetzten Batteriezellen aufweist, wobei eine Kontaktfeder (7) in einen Führungsgang (9) des ersten Aufnahmekörpers (2) eingesetzt ist, der in die Durchtrittsöffnung (6) zum stoffschlüssigen Verbinden der Kontaktfeder (7) mit der in den zweiten Aufnahmekörper (3) eingesetzten Batteriezelle mündet, und dass die Kontaktfeder (7) Kontaktzungen (8) zum lösbaren Verbinden der in den ersten Aufnahmekörper (2) eingesetzten Batteriezelle bildet..
Patent WO-2020210857-A1 (WO)
Inventor: VEIGL MICHAEL FRIEDHELM
IPC: H01M10/613
Filed: 2020-04-20
Abstract: Es wird eine Tasche (1) mit einer Taschenwand (2) aus einem flexiblen Laminat (7), das einen Dämmschichtbildner (7.1) aufweist, und mit einem die Tasche (1) verschließbaren Verschluss (6) gezeigt. Um hohe Brandbeständigkeit zu erreichen wird vorgeschlagen, dass das Laminat (7) als Träger ein flexibles Gewebe (7.2), insbesondere Glasfasergewebe, aufweist, das mit dem Dämmschichtbildner (7.1) beschichtet ist.
Patent AU-2002306864-A1 (AU)
Title: An arbitrary waveform synthesizer using a free-running ring oscillator
Inventor: CARLEY ADAM L
IPC: H03K3/84
Filed: 2002-03-25
Abstract: A waveform generator includes a plurality of delay elements such as in a delay line circuit of a free-running oscillator, phase locked loop (PLL) circuit or delay locked loop (DLL) circuit, an algebra module, a switching module and an output module. The oscillator includes a plurality of delay elements and a plurality of taps disposed between the delay elements, with each tap providing a uniquely phased, oscillating transition signal. The algebra module includes an algebra data input port, a clock input port and an algebra data output port. The algebra module generates a signal at the algebra data output port indicating a first rising edge of the arbitrary waveform in response to a signal received at the algebra data input port. The switching module includes a switch input port in electrical communication with the algebra data output port, a plurality of switch tap input ports in electrical communication oscillator taps and switch output port. At the switch output port, the switch module provides a first transition signal selected from one of the plurality of oscillator taps in response to the signal indicative of a first rising edge received at the switch input port. The output module includes a transition signal input port in electrical communication with the switch output port, a window input port in electrical communication with the algebra data output port and a waveform output port in electrical communication with the clock input port of the algebra module. In order to generate multiple output waveforms, there may be a plurality of switching modules and a corresponding plurality of output modules. Each corresponding switching module/output module pair is dedicated to producing a corresponding output signal.
Patent AU-2002339356-A1 (AU)
Title: Holding element, method for producing a holding element and use of extruded elements
Inventor: OVER HELMUT
IPC: E06B1/60
Filed: 2002-10-11
Abstract: The holding element (1) has several bodies (e.g. 2, 3) to receive components (15, 16) such as window frames. At least one of the bodies includes an extruded element. One of the bodies may be solid. One of them may include an aluminum alloy. One may be of reduced cross section, e.g. produced by taking material away from it.
Patent AU-2003202763-A1 (AU)
Title: Use of anethole dithiolethione in lung cancer chemoprevention
Inventor: LAM STEPHEN
IPC: A61P35/00
Filed: 2003-02-13
Abstract: The present invention relates to the use of 5-(p-methoxyphenyl)-1,2-dithiole-3-thione or of a pharmaceutical derivative thereof for the preparation of a medicament for preventing lung cancer in a mammalian subject, especially for preventing or reducing the appearance of new dysplastic lesions, or the progression of pre-existing dysplastic lesions in the subject, or for improving regression of existing dysplastic lesions.
Patent AU-2003214765-A1 (AU)
Title: New method
Inventor: OLSSON CHARLOTTA
IPC: C12Q1/68
Filed: 2003-04-04
Abstract: A method for determining the sequence of a nucleic acid molecule includes the steps of: a) providing a single-stranded form of the nucleic acid molecule; b) hybridizing a primer to the single stranded form of the nucleic acid molecule to form a template/primer complex; c) enzymatically extending the primer by the addition of a polymerase and a mixture of at least one nucleotide and at least one labeled derivative of the at least one nucleotide, wherein the at least one labeled derivative of the at least one nucleotide includes a label linked to the nucleotide via a cleavable link and wherein the amount of labeled derivative of the at least one nucleotide in the mixture of the at least one nucleotide and the labeled derivative of the at least one nucleotide is within the range of 1-50 mole-%, 1-40 mole-%, 1-30 mole-%, or 1-20 mole-%. d) determining the type of nucleotide added to the primer; and e) repeating steps c) to d) at least once.
Patent AU-2003217206-A1 (AU)
Title: Method for chocolate coating of soft confectionery centers
Inventor: RABINOVITCH KEVIN L
IPC: A23G7/00
Filed: 2003-01-15
Abstract: The present invention is directed to a method of coating soft confectionery centers with chocolate. The method comprises the steps of: mixing the soft confectionery centers having a bed temperature of from about 0° C. to about 15° C.; applying chocolate onto the soft confectionery centers, wherein the chocolate is at a temperature of from about 36° C. to about 50° C.; and cooling the chocolate covered soft confectionery centers.
Patent AU-2003227934-A1 (AU)
Title: System and method for digital watermarking of data repository
Inventor: AGRAWAL RAKESH
IPC: G06F21/10
Filed: 2003-05-14
Abstract: A method and system for enhancing security in a database by establishing a bit pattern using secret information, the pattern establishing a watermark that can be detected in a copy (authorized or not) of the database only by using the secret information.
Patent AU-2003237140-A1 (AU)
Title: Improved variable gain amplifier
Inventor: JEN HUNG-MIN
IPC: H03G3/28
Filed: 2003-04-29
Abstract: The present invention provides a variable gain amplifier with a plurality of gain stages in which each of the gain stages is implemented using a circuit that implements a neutralization approach. This variable gain amplifier provides stable operation characteristics as different gain stages within the variable gain amplifier are turned on and off. This variable gain amplifier also increases linearity across the entire operating range. Additionally, the variable gain amplifier of the present invention provides a constant input impedance through different gain settings. Further, the present invention provides a variable gain amplifier in which each of the various gain stages therein maximize the available voltage swing. Finally, this variable gain amplifier improves common-mode rejection performance and attenuates unwanted harmonics.
Patent AU-2003245795-A1 (AU)
Title: Programmable pump for the injection of medicaments
Inventor: MORI PETER
IPC: G16H20/17
Filed: 2003-07-16
Abstract: The programmable pump, for the injection of medications, has two sections coupled together by a bayonet link (36) and a release catch (22). The cassette module (12) contains the fluid for injection, and has an electronic memory programmed for the injection regime. It is also fitted with a switch (30) to operate the pump at a higher speed to extract air from the fluid bag. The peristaltic pump module (10) is activated by the program, to deliver the doses according to the set timetable, and it also has an electronic memory containing data to ensure the security of the treatment. A microprocessor validates the compatibility of the data held in the two memories.
Patent AU-2003247311-A1 (AU)
Title: A method for load balancing using bottleneck load balancing
Inventor: LINDBERG PER
IPC: H04L45/24
Filed: 2003-07-21
Abstract: A method to determine the load balancing a router should use on its outgoing links for traffic to each destination. It is based on link loads. Link weights and lengths of the shortest paths as calculated by ordinary IP routing protocols are only used to determine the allowed routing alternatives. To decide the load sharing on the outgoing links for traffic to a certain destination t, a router uses bottleneck load values for each of the alternative routes. Bottleneck loads are calculated through a special protocol starting from each destination t, such that they represent the maximal link load along a path and an average value of the maximal link loads in case that a path is split up in more than one. The load sharing parameters are then updated by use of the calculated bottleneck load values in order to level out the bottleneck loads.
Patent AU-2003253936-A1 (AU)
Title: Biocidal composition containing halogenated hydantoin and paraffin wax
Inventor: HOWARTH JONATHAN N
IPC: C07D233/82
Filed: 2003-07-10
Abstract: The dry blends comprise a powdery or finely-divided halogenated hydantoin, and a paraffin wax that is compatible with the halogenated hydantoin. The paraffin wax is a hydrocarbon paraffin wax and/or a chlorinated paraffin wax. Shape-retentive compacted compositions are formed by pressure compacting such blends. Preferred halogenated hydantoins are 1,3-dihalo-5,5-dialkylhydantoins.
Patent AU-2003267075-A1 (AU)
Title: Methods for inhibiting intergranular corrosion of metal surfaces
Inventor: KLATSKIN STUART D
IPC: B22D11/124
Filed: 2003-09-10
Abstract: The present invention is directed toward the use of a reaction product of an alkynediol and a polyalkylene polyamine to inhibit intergranular corrosion of metal surfaces in industrial processing systems caused by spray water mist or condensation.
Patent AU-2003272095-A1 (AU)
Title: Process for producing microbial fat or oil having lowered unsaponifiable matter content and said fat or oil
Inventor: KAWASHIMA HIROSHI
IPC: A23L33/00
Filed: 2003-10-09
Abstract: A process for producing oil comprising a highly unsaturated fatty acid as a constituent fatty acid. 
A microorganism such as Mortierella is cultured in a medium containing nitrogen source at a concentration of 2 to 15% in a culture tank equipped with an agitation impeller. The nitrogen source is previously sterilized at a pH of not more than 5.
Patent AU-2003297200-A1 (AU)
Title: Implantable medical device assembly
Inventor: CAMPBELL CAREY V
IPC: A61F2/06
Filed: 2003-12-16
Abstract: The present invention is directed to implantable medical device assemblies. The assemblies are primarily used to introduce and deposit implantable medical devices in the vasculatures of implant recipients. The principle implantable medical device used in the assembly is an expandable element in the form of an endovascular device. The expandable element is maintained in a compacted configuration during introduction of the device into the vasculature with a confinement means. The expandable element is released from the confinement means at an implantation site with a control line. The control line has high tensile strength, high modulus, structural rigidity, and low compressibility. These features of the control line provide a practitioner with tactile feedback of the release of the expandable element from the confinement means. The tactile feedback is present during the entire deployment of the expandable element. The tactile feedback enables the practitioner to better track and control deployment of the expandable element at an implantation site.
Patent WO-2004062923-A1 (WO)
Title: A 3-d product printing system with a foreign object incorporation facility
Inventor: SILVERBROOK KIA
IPC: B29C67/00
Filed: 2004-01-09
Abstract: A system that prints three dimensional products, the system including an object incorporation device (602) that inserts at least one non-printed object (604) into at least one cavity (608) created during the printing process, the object incorporation device incorporating the at least one non-printed object into the at least one cavity during the printing of the respective printed object.
Patent WO-2004108742-A1 (WO)
Title: Technique d'identification de structures de glycane au moyen e donnees de spectrometrie de masse
Inventor: JOSHI HIREN
IPC: G06F19/00
Filed: 2004-06-10
Abstract: Cette invention concerne une technique permettant de caractériser la structure ou la sous-structure d'un glycane ou d'un dérivé de glycane, qui consiste à déduire expérimentalement la masse d'une molécule de glycane non identifiée et de comparer à des structures de glycane identifiées et caractérisées afin de sélectionner des structures candidates pour la molécule de glycane. On déduit ensuite expérimentalement la masse des fragments de molécules de glycane et l'on procède à une fragmentation théorique des candidats sélectionnées. La masse des fragments de molécule de glycane non identifiée est mise en regard avec la masse des fragments déduits par théorie des structures candidates. Suit un classement destiné à produire des notes classées par degré de certitude pour chacune des structures candidates, consistant à comparer les masses des fragments déduits expérimentalement aux masses des fragments déduits par la théorie. L'invention porte sur deux méthodes de classement : par segmentation et par mise en correspondance. Si le degré de certitude obtenue pour les notes les plus élevées est insuffisant, on poursuit en répétant le processus avec prise en compte de schémas de clivage plus complexes dans l'opération de fragmentation théorique, ou bien en utilisant des spectres supplémentaires.
Patent AU-2004220763-A1 (AU)
Title: T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection
Inventor: ZHANG JINGWU Z
IPC: C12Q1/68
Filed: 2004-10-15
Abstract: In one embodiment, the present invention is directed to a first oligonucleotide comprising the sequence of or derived from 5'-CTAGGGCGGGCGGGACTCACCTAC-3' or the nucleic acid sequence complementary thereto. The first oligonucleotide can be used with a nucleic acid of between 15 and 30 nucleotides that does not comprise the sequence of the first oligonucleotide and is found in the region from Vbeta to Jbeta of the Vbeta13.1 gene in Vbeta13.1 T cells, wherein the sequences of the oligonucleotide and the nucleic acid are not found on the same strand of the Vbeta13.1 gene pair, to amplify a portion of the Vbeta13.1 gene. Alternatively, the first oligonucleotide can be used with a labeling moiety in methods of detecting a LGRAGLTY motif found in T cell receptors of Vbeta13.1 T cells. This motif is associated with autoimmune diseases, such as multiple sclerosis (MS). Once the motif is detected, the autoimmune disease can be treated or its progress monitored. The autoimmune disease can be treated by administering a peptide comprising the LGRAGLTY motif.
Patent AU-2004238496-A1 (AU)
Title: Bottle seal
Inventor: SPATZ GUNTER
IPC: B67B3/12
Filed: 2004-05-05
Abstract: The invention relates to a closure for closing a bottle having a bottleneck ( 1 ) with an opening on which bottleneck an outer thread ( 5,6 ) is formed in the vicinity of the opening. In order to provide a closure that is easy to handle and can be fabricated inexpensively, the closure ( 2 ) has at least one, and particularly several, deformation regions which are plastically deformed so that in the outer peripheral surface of the closure they form indentations ( 21,22 ) and internally ( 25,26 ) they are adapted to the thread ( 5,6 ).
Patent AU-2004263737-A1 (AU)
Title: Irradiated butene-1 polymer compositions
Inventor: BUGADA DANIELE C
IPC: C08L23/20
Filed: 2004-07-26
Abstract: An irradiated butene-1 polymer material characterized by high melt strength and softness, and composiiton of this high melt strength butene-1 polymer with non-irradiated butene-1 polymer materials having enhanced crystallization properties.
Patent AU-2004275826-A1 (AU)
Title: OROS push-stick for controlled delivery of active agents
Inventor: WONG ALFREDO M
IPC: A61K9/22
Filed: 2004-09-24
Abstract: A sustained release dosage form is provided comprising a pharmaceutically active agent and pharmaceutically acceptable salts thereof and adapted to release as an erodible solid over a prolonged period of time, wherein the dosage form provides burst release of the pharmaceutically active agent without the use of an immediate release drug coating. The dosage form is able to deliver high doses of poorly soluble or slowly dissolving active agents at a controlled rate. Methods of using the dosage forms to treat disease or conditions in human patients are also disclosed.
Patent AU-2004284456-A1 (AU)
Title: Methods for quantitative determination of methylation density in a DNA locus
Inventor: JEDDELOH JEFFREY A
IPC: G01N33/50
Filed: 2004-10-21
Abstract: The present invention is a novel method of determining the average DNA methylation density of a locus of interest within a population of DNA fragments.
Patent AU-2004293658-A1 (AU)
Title: Plasmid maintenance
Inventor: CRANENBURGH ROCKY MARC
IPC: C12N15/72
Filed: 2004-11-22
Abstract: The invention relates to a system for stable maintenance of a plasmid, to host cells for use in this system and to methods of using the system to obtain a plasmid useful in medical applications. In particular, the invention provides transformed host cell containing: i) a chromosomal gene which inhibits cell growth; and ii) a plasmid encoding an antisense sequence, wherein the antisense sequence encoded by the plasmid inhibits the action of the chromosomal gene, thereby permitting cell growth and a method for stable maintenance of a plasmid in a host cell in vivo.
Patent WO-2006007661-A1 (WO)
Title: Dispositif de fixation d'une plaque d'usure
Inventor: HALE PETER
Filed: 2005-07-22
Abstract: L'invention porte sur un dispositif de fixation d'une plaque d'usure (100) dans un rotor (30) de compresseur à impact à arbre rotatif. Le dispositif de fixation comprend un agencement d'une ou plusieurs parties saillantes et d'un ou plusieurs évidements s'adaptant les uns aux autres. L'une des parties saillantes (40) ou évidements (42) est placé sur la plaque d'usure (100) et l'autre partie saillante correspondante (40) ou évidement (42) est disposé sur une des parois latérales (23) ou plaque terminale (16,18) du rotor (30) du compresseur à impact.
Patent WO-2006060855-A1 (WO)
Inventor: KNORR ANDREW KARL
IPC: B27B25/00
Filed: 2005-12-06
Abstract: A process and associated devices to enable efficient processing of radial wedge sectors of timber by the removal of the necessity for manual handling of the wedge sectors and the provision of a system of mechanical handling of wedge sectors to provide aligned wedge sectors for further processing.
Patent AU-2005209687-A1 (AU)
Title: Use of inhibitors of the Renin-Angiotensin system in the prevention of cardiovascular events
Inventor: RANGOONWALA BADRUDIN
IPC: A61K31/00
Filed: 2005-09-13
Abstract: Use of an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with an other antihypertensive, a cholesterol lowering agent, a diuretic or aspirin, in the manufacture of a medicament for the prevention of cardiovascular events; a method of preventing cardiovascular events comprising administering to a patient in need of such prevention an effective amount of an inhibitor of the renin angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with an other antihypertensive, a cholesterol lowering agent, a diuretic or aspirin; and a combination product containing an an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof and a cholesterol lowering agent.
Patent AU-2005318865-A1 (AU)
Title: Container loading apparatus
Inventor: EATON KENNETH JOHN
IPC: B60P1/64
Filed: 2005-12-23
Abstract: A container loading apparatus for a truck (10) comprises a first pair of opposed container attachment arms (14) and a second pair of opposed secondary support arms (22), rotatable about horizontal axes from a stowed position in which the container attachment arms (14) and the secondary support arms (22) are disposed substantially beneath a loaded container, the secondary support arms (22) being rotatable relative to the truck (10) by first actuation rams (30) and the container attachment arms (14) rotatable relative to the secondary support arms (22) by second actuation rams (32).
Patent AU-2005327056-A1 (AU)
Title: Computer-implemented method and computer-based system for validating DNA sequencing data
Inventor: EMLER STEFAN
IPC: G16B30/10
Filed: 2005-02-11
Abstract: To validate DNA sequencing data from sequence data of one or more DNA fragments, a server (3) obtains a target specification from a user via a telecommunications network (2). From a set of one or more possible reference sequences (42), related to the target specification and stored in a database (4), the server (3) selects the reference sequence having the highest correlation with the fragment sequence data. For example, if the target specification identifies a gene sequence, then the reference sequence is selected from a set of variants of the gene sequence. Automatically, the server (3) aligns the fragment sequence data with the selected reference sequence and identifies any sequence positions where nucleotide codes of aligned fragment sequence data and selected reference sequence do not correspond. For validating DNA sequencing data, selection of reference sequence and identification of ambiguous nucleotide codes can be performed without human intervention, thus, the speed and reliability of the validation process is improved.